Fertility preservation is a key component of cancer management in young patients. Cancer treatment can often lead to reduced fertility. Cancer patients should be aware of options available for preserving their fertility and future reproduction prior to their cancer treatment. Reproduction in the context of cancer raises a number of ethical issues related to both patient and offspring welfare. Evidence suggests that cancer treatment often commences without adequate consideration of fertility preservation and that current services have a strong potential for improvement. Early referral of patients to a fertility specialist will allow consideration and discussion of the full range of fertility preservation options. It’s a multidisciplinary approach that involves specialists in oncology, assisted reproduction, embryology and clinical genetics.
The diagnosis and treatment of cancer often pose a threat to fertility. Methods of fertility preservation are evolving quickly, yet little has been published in the medical oncology literature regarding this topic. Health-care providers should be prepared to discuss fertility with patients regardless of their age and marital status and their families before initiation of therapy to make them understand the possible reproductive consequences of cancer treatment and know the alternatives available to preserve fertility.
For female cancer patients who run the risk of losing their fertility during the cancer treatment, science has enabled an option to preserve their fertility. However, there is no doubt, that many women across the world are utilizing this technique for non-medical reasons like career prospects, etc. This trend is gaining traction tremendously, with an exponential sky high surge in the same.
At Milann, we are proud to offer our patients the most advanced equipment, world-class facilities and the latest technology to meet the growing needs for fertility preservation.
Let us know how we can help.